Company Overview
ORIC PHARMACEUTICALS, INC.
ORICRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-129M
2025 FY
Shares Outstanding
88M
2025 FY
EPS
-1.47USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1796280
Exchange
Nasdaq
Location
US